v3 Template
T

Theralase® Technologies Inc.

Healthcare / Medical Technology TORONTO, ON ~420 employees
Founded
--
Employees (Est.)
~420
21 leaders known
Total Funding
$22.2M
Funding Rounds
17
Last Funding
2025-12-23

About Theralase® Technologies Inc.

Theralase Technologies Inc. is a company focused on developing innovative medical technologies to destroy cancer, bacteria, and viruses, as well as to provide pain relief through advanced laser therapies. Their mission is encapsulated in their slogans 'Destroying Cancer at the Speed of Light' and 'Healing at the Speed of Light'.

Products & Services

Anti-Cancer Therapy (ACT):Uses patented light-activated Photo Dynamic Compounds (PDCs) to safely and effectively destroy cancer, bacteria, and viruses.
Cool Laser Therapy (CLT):Utilizes proprietary and patented medical laser systems to safely and effectively eliminate knee pain.

Specialties

Anti-Cancer Therapy Photo Dynamic Therapy Cool Laser Therapy Medical Laser Systems Pain Management

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Non-Brokered Private Placement
T: -
FT: Non-Brokered Private Placement
A: 1334650
MR: -
FA: 1,334,650 CAD
FAN: 1334650
D: 2025-12-23
FD: 2025-12-23
-
2 RT: Non-brokered private placement
T: -
FT: Non-brokered private placement
A: 2000000
MR: -
FA: up to $CAN 2,000,000
FAN: 2000000
D: 2025-12-12
FD: 2025-12-12
-
3 RT: Warrant Extension
T: -
FT: Warrant Extension
A: 644000
MR: -
FA: 644,000 CAD (potential from exercising 1,840,000 warrants at $0.35 each)
FAN: 644000
D: 2025-08-29
FD: 2025-08-29
-
4 RT: Non-Brokered Private Placement
T: -
FT: Non-Brokered Private Placement
A: 672627
MR: -
FA: approximately $CAN 672,627
FAN: 672627
D: 2025-07-28
FD: 2025-07-28
-
5 RT: Non-brokered Private Placement
T: -
FT: Non-brokered Private Placement
A: 571000
MR: -
FA: approximately $CAN 571,000
FAN: 571000
D: 2025-06-17
FD: 2025-06-17
-
6 RT: Non-brokered Private Placement
T: -
FT: Non-brokered Private Placement
A: 419124
MR: -
FA: $CAN 419,124
FAN: 419124
D: 2025-04-14
FD: 2025-04-14
-
7 RT: Non-brokered Private Placement
T: -
FT: Non-brokered Private Placement
A: 310200
MR: -
FA: approximately $CAN 310,200
FAN: 310200
D: 2025-03-11
FD: 2025-03-11
-
8 RT: Non-brokered Private Placement
T: -
FT: Non-brokered Private Placement
A: 666400
MR: -
FA: approximately $CAN 666,400
FAN: 666400
D: 2024-11-15
FD: 2024-11-15
-
9 RT: Warrant Extension
T: -
FT: Warrant Extension
A: 350000
MR: -
FA: 350000
FAN: 350000
D: 2024-11-12
FD: 2024-11-12
-
10 RT: Non-Brokered Private Placement
T: -
FT: Non-Brokered Private Placement
A: 544000
MR: -
FA: $CAN 544,000
FAN: 544000
D: 2024-09-24
FD: 2024-09-24
-
11 RT: Warrant Extension (from previous private placement)
T: -
FT: Warrant Extension (from previous private placement)
A: 3500000
MR: -
FA: 10,000,000 warrants at $0.35 per share
FAN: 3500000
D: 2024-09-19
FD: 2024-09-19
-
12 RT: Non-Brokered Private Placement
T: -
FT: Non-Brokered Private Placement
A: 775000
MR: -
FA: 775,000
FAN: 775000
D: 2024-07-08
FD: 2024-07-08
-
13 RT: Non-Brokered Private Placement
T: -
FT: Non-Brokered Private Placement
A: 1200000
MR: -
FA: CAN 1,200,000
FAN: 1200000
D: 2024-02-05
FD: 2024-02-05
-
14 RT: Non-brokered Private Placement
T: -
FT: Non-brokered Private Placement
A: 1170000
MR: -
FA: 1,170,000
FAN: 1170000
D: 2023-11-29
FD: 2023-11-29
-
15 RT: Non-brokered Private Placement
T: -
FT: Non-brokered Private Placement
A: 1500000
MR: -
FA: up to $CAN 1.5 M
FAN: 1500000
D: 2023-11-17
FD: 2023-11-17
-
16 RT: Brokered Offering (LIFE Financing)
T: -
FT: Brokered Offering (LIFE Financing)
A: 5300000
MR: -
FA: Up to C$5,300,000
FAN: 5300000
D: 2023-10-23
FD: 2023-10-23
1 investors
17 RT: Non-brokered Private Placement
T: -
FT: Non-brokered Private Placement
A: 1200000
MR: -
FA: approximately $1,200,000
FAN: 1200000
D: 2023-06-30
FD: 2023-06-30
-
Non-Brokered Private Placement Latest
2025-12-23
$1.3M
Non-brokered private placement 2025-12-12
$2.0M
Warrant Extension 2025-08-29
$644K

View 16 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

R

Roger Dumoulin-White

President and Chief Executive Officer

K

Kristina Hachey

Chief Financial Officer, Director

A

Arkady Mandel

Chief Scientific Officer

G

Guy Anderson

Director

M

Matthew Perraton

Chairman of the Board, Director

R

Randy Bruder

Director

View 18 more team members with Pro

Unlock Full Team Directory

Recent News

Theralase® Technologies Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare / Medical Technology
Company Size
~420 employees (est.)
Locations
TORONTO, ON
Toronto, ON
Toronto, Ontario, Canada +1 more

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro